Fair Value Please, page-287

good posts - it's getting very interesting. Still think the Chinese will come to the party. They're already in the equation. To reiterate the tie ups, there's the Li Ka Shing Gene and Therapy Centre (funded to the tune of 4.5M AUD by LKS), an organisation with Prof Rasko as its head, who is clearly a fan of the Cymerus tech and in a sense promotes it through presentations. The NHMRC Clinical Trials Centre collaborates with the LKS Gene and Therapy Centre. The NHMRC is of course funding the next CYP trial - the costs of such trials range between 7 and 19 million USD. Lots of serious money entering our sector. And as we've seen from media articles, State Path and China Resources are looking for a deal in Aus.